Under the CEPA, India has granted quota-based tariff concessions to certain Omani goods such as dates, marble, copper weld wire, aluminium ...

The state government views Bhogapuram Airport not merely as an infrastructure project, but as a transformational asset for the entire North...

Prime Minister Narendra Modi will inaugurate the Alluri Sitarama Raju International Airport on August 1. This new airport is expected to bo...

The new wave of India’s FTAs is expected to bolster opportunities for Indian exporters in developed markets through its nine new FTAs with ...

PAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...

The report noted that India remains one of the relative beneficiaries of the new US tariff regime overall.

Pharma mutual funds are leading returns in CY2026, driven by strong earnings, defensive demand, and US export growth. Despite recent outper...

India secured an advantage in United States tariffs due to ongoing trade negotiations. A significant portion of Indian exports remain exemp...

US pharma tariffs: Experts have urged a shift towards global diversification and prioritising innovation for Indian pharma to lessen market...

About forty-five percent of India's exports to the US are excluded from new tariffs. The remaining fifty-five percent of exports will attra...

India's merchandise exports to its free trade agreement (FTA) partner countries rose 25% year-on-year to $43.14 billion in the April-June q...

The US Section 301 tariff has escalated cost challenges for Indian exporters, but it simultaneously provides a unique advantage. Competing ...

Production Linked Incentive schemes, which aim to boost manufacturing and attract significant investments, have disbursed Rs 35,354 crore t...

US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...

President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...